{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:10:47Z","timestamp":1771877447083,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00277-013-1836-8","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T05:41:06Z","timestamp":1372743666000},"page":"531-532","source":"Crossref","is-referenced-by-count":5,"title":["Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome"],"prefix":"10.1007","volume":"93","author":[{"given":"Jan Moritz","family":"Middeke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Normi","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefani","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"issue":"16","key":"1836_CR1","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A (2008) Cairo MS Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16):2767\u20132778. doi: 10.1200\/JCO.2007.15.0177 , PMID: 18509186","journal-title":"J Clin Oncol"},{"issue":"19","key":"1836_CR2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364(19):1844\u20131854. doi: 10.1056\/NEJMra0904569 , PMID: 21561350","journal-title":"N Engl J Med"},{"issue":"1","key":"1836_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1):3\u201311, PMID: 15384972","journal-title":"Br J Haematol"},{"issue":"3","key":"1836_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1078155209348719","volume":"16","author":"LD Kennedy","year":"2010","unstructured":"Kennedy LD, Ajiboye VO (2010) Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome. J Oncol Pharm Pract 16(3):205\u2013213. doi: 10.1177\/1078155209348719 , PMID: 19923162","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"1836_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08998280.2005.11928082","volume":"18","author":"S Ueng","year":"2005","unstructured":"Ueng S (2005) Rasburicase (Elitek): a novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent) 18(3):275\u2013279, PMID: 16200184","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"12","key":"1836_CR6","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1080\/10428190600967204","volume":"47","author":"N Kizer","year":"2006","unstructured":"Kizer N, Martinez E, Powell M (2006) Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma 47(12):2648\u20132650, PMID: 17169811","journal-title":"Leuk Lymphoma"},{"key":"1836_CR7","doi-asserted-by":"crossref","unstructured":"Chaudhari T, McGuire W (2012) Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev. (2):CD006817. doi: 10.1002\/14651858.CD006817.pub3 . PMID: 22786499","DOI":"10.1002\/14651858.CD006817.pub3"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1836-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1836-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1836-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T22:43:34Z","timestamp":1563317014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1836-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1836-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}